Holdings of Biotechnology Fund
Rydex Series Funds · Original filing · Compare with another fund · Report an error
- Net assets
- 135.1M $ including 133.3M $ in equities, 98.7 %
- Positions
- 72 in 9 countries
- Top ten
- 36.7 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | AbbVie Inc | 45,923 | 10M $ | 7.39 % |
| 2 | Amgen Inc | 20,093 | 7.1M $ | 5.23 % |
| 3 | Gilead Sciences Inc | 48,042 | 6.7M $ | 4.96 % |
| 4 | Vertex Pharmaceuticals Inc | 12,119 | 5.4M $ | 4.01 % |
| 5 | Regeneron Pharmaceuticals, Inc. | 6,224 | 4.8M $ | 3.56 % |
| 6 | Alnylam Pharmaceuticals Inc | 10,632 | 3.5M $ | 2.60 % |
| 7 | Insmed Inc | 20,277 | 3.3M $ | 2.45 % |
| 8 | BEONE MEDICINES LTD | 10,395 | 3.1M $ | 2.29 % |
| 9 | Natera Inc | 14,145 | 2.8M $ | 2.09 % |
| 10 | United Therapeutics Corp | 4,711 | 2.8M $ | 2.07 % |
| 11 | Biogen Inc | 14,803 | 2.7M $ | 2.01 % |
| 12 | Royalty Pharma PLC | 55,739 | 2.7M $ | 1.98 % |
| 13 | Illumina Inc | 19,053 | 2.3M $ | 1.74 % |
| 14 | Revolution Medicines Inc | 23,475 | 2.3M $ | 1.69 % |
| 15 | Moderna Inc | 43,818 | 2.2M $ | 1.65 % |
| 16 | AstraZeneca PLC | 10,974 | 2.2M $ | 1.60 % |
| 17 | Argenx SE | 2,961 | 2.2M $ | 1.60 % |
| 18 | Incyte Corp | 22,317 | 2.1M $ | 1.56 % |
| 19 | Viatris Inc | 150,073 | 2M $ | 1.50 % |
| 20 | Bridgebio Pharma Inc | 26,764 | 2M $ | 1.47 % |
| 21 | Alkermes PLC | 56,068 | 2M $ | 1.47 % |
| 22 | Jazz Pharmaceuticals PLC | 10,448 | 2M $ | 1.46 % |
| 23 | Neurocrine Biosciences Inc | 14,527 | 1.9M $ | 1.42 % |
| 24 | Guardant Health Inc | 20,606 | 1.9M $ | 1.41 % |
| 25 | Roivant Sciences Ltd | 68,372 | 1.9M $ | 1.40 % |
| 26 | Ionis Pharmaceuticals Inc | 24,870 | 1.9M $ | 1.38 % |
| 27 | Exelixis Inc | 40,607 | 1.7M $ | 1.29 % |
| 28 | Medpace Holdings Inc | 3,540 | 1.7M $ | 1.26 % |
| 29 | BioMarin Pharmaceutical Inc | 29,738 | 1.7M $ | 1.24 % |
| 30 | Apellis Pharmaceuticals Inc | 41,107 | 1.7M $ | 1.22 % |
| 31 | Arrowhead Pharmaceuticals Inc | 26,370 | 1.7M $ | 1.22 % |
| 32 | Cytokinetics Inc | 24,093 | 1.6M $ | 1.18 % |
| 33 | Vaxcyte Inc | 26,383 | 1.5M $ | 1.14 % |
| 34 | CRISPR Therapeutics AG | 32,054 | 1.5M $ | 1.13 % |
| 35 | Halozyme Therapeutics Inc | 22,712 | 1.5M $ | 1.09 % |
| 36 | BioNTech SE | 16,159 | 1.4M $ | 1.06 % |
| 37 | Axsome Therapeutics Inc | 8,171 | 1.4M $ | 1.02 % |
| 38 | Ascendis Pharma A/S | 5,974 | 1.4M $ | 1.01 % |
| 39 | Cogent Biosciences Inc | 34,752 | 1.3M $ | 0.99 % |
| 40 | Arcellx Inc | 11,645 | 1.3M $ | 0.99 % |
| 41 | TG Therapeutics Inc | 39,225 | 1.3M $ | 0.96 % |
| 42 | PTC Therapeutics Inc | 18,935 | 1.3M $ | 0.96 % |
| 43 | Scholar Rock Holding Corp | 25,883 | 1.3M $ | 0.94 % |
| 44 | Madrigal Pharmaceuticals Inc | 2,329 | 1.2M $ | 0.90 % |
| 45 | Mirum Pharmaceuticals Inc | 13,080 | 1.2M $ | 0.89 % |
| 46 | Protagonist Therapeutics Inc | 11,198 | 1.2M $ | 0.87 % |
| 47 | Amicus Therapeutics Inc | 76,280 | 1.1M $ | 0.82 % |
| 48 | Rhythm Pharmaceuticals Inc | 12,158 | 1.1M $ | 0.78 % |
| 49 | Apogee Therapeutics Inc | 12,066 | 1M $ | 0.75 % |
| 50 | Kymera Therapeutics Inc | 11,658 | 971K $ | 0.72 % |
| 51 | Twist Bioscience Corp | 20,054 | 953K $ | 0.71 % |
| 52 | Viking Therapeutics Inc | 29,278 | 952.7K $ | 0.71 % |
| 53 | Summit Therapeutics Inc | 49,213 | 933.1K $ | 0.69 % |
| 54 | Nuvalent Inc | 9,053 | 927.5K $ | 0.69 % |
| 55 | ACADIA Pharmaceuticals Inc | 40,673 | 905.4K $ | 0.67 % |
| 56 | Travere Therapeutics Inc | 30,251 | 898.8K $ | 0.67 % |
| 57 | Sarepta Therapeutics Inc | 40,226 | 875.3K $ | 0.65 % |
| 58 | Celcuity Inc | 7,658 | 874.1K $ | 0.65 % |
| 59 | Arcutis Biotherapeutics Inc | 36,923 | 869.9K $ | 0.64 % |
| 60 | Veracyte Inc | 26,685 | 859.5K $ | 0.64 % |
| 61 | Liquidia Corp | 22,146 | 835.8K $ | 0.62 % |
| 62 | Beam Therapeutics Inc | 31,896 | 760.1K $ | 0.56 % |
| 63 | Ultragenyx Pharmaceutical Inc | 34,041 | 713.2K $ | 0.53 % |
| 64 | Praxis Precision Medicines Inc | 2,092 | 674K $ | 0.50 % |
| 65 | GRAIL Inc | 12,830 | 663.1K $ | 0.49 % |
| 66 | Soleno Therapeutics Inc | 19,659 | 658.2K $ | 0.49 % |
| 67 | Recursion Pharmaceuticals Inc | 208,931 | 641.4K $ | 0.47 % |
| 68 | Krystal Biotech Inc | 2,474 | 639.1K $ | 0.47 % |
| 69 | LEGEND BIOTECH CORP | 35,054 | 634.1K $ | 0.47 % |
| 70 | Intellia Therapeutics Inc | 49,463 | 634.1K $ | 0.47 % |
| 71 | ADMA Biologics Inc | 65,635 | 591.4K $ | 0.44 % |
| 72 | Akero Therapeutics Inc | 17,387 | 1.7 $ |
Sector breakdown
- Health care 48.1 %
- Unattributed 51.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 88.6 %
- Ireland 3.0 %
- United Kingdom 1.6 %
- Netherlands 1.6 %
- Bermuda 1.4 %
- Switzerland 1.1 %
- Germany 1.1 %
- Denmark 1.0 %
- Cayman Islands 0.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 63 | 118.1M $ | 88.64 % |
| 2 | Ireland | 2 | 4M $ | 2.97 % |
| 3 | United Kingdom | 1 | 2.2M $ | 1.62 % |
| 4 | Netherlands | 1 | 2.2M $ | 1.62 % |
| 5 | Bermuda | 1 | 1.9M $ | 1.42 % |
| 6 | Switzerland | 1 | 1.5M $ | 1.14 % |
| 7 | Germany | 1 | 1.4M $ | 1.08 % |
| 8 | Denmark | 1 | 1.4M $ | 1.03 % |
| 9 | Cayman Islands | 1 | 634.1K $ | 0.48 % |
Cite this page
Titelia. "Holdings of Biotechnology Fund". https://titelia.com/en/funds/S000003802